InvestorKleiner Perkins is a venture capital firm based in Menlo Park, California, founded in the 1970s. It partners with entrepreneurs across various sectors, providing capital and resources from inception to IPO.

BioStar Capital is a Michigan-based venture capital firm that specializes in transformative medical technologies, particularly in cardiology and orthopedics. The firm integrates healthcare professionals into its investment strategy to enhance clinical validation and strategic advisement.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Third-party rankings
| Ranking | Edition | Listed as | Position | Since last edition | Trust | What it measures |
|---|---|---|---|---|---|---|
| Strebulaev-Jackson Venture Ranking: Top 50 Biotech VC Firms | 2026 | BioStar | #48 | No prior edition | B | Performance |
BioStar Capital, founded in 2005 by Dr. Louis A. Cannon, is a venture capital firm headquartered in Petoskey, Michigan. The firm focuses on early- and late-stage investments in transformative medical technologies, particularly in the fields of cardiology, orthopedics, and robotics. With a unique model that integrates key opinion leader physicians into the General Partner structure, BioStar leverages clinical expertise to validate and guide its portfolio companies. The firm operates five venture capital funds and has invested in over 50 medical device and technology companies, achieving a notable exit rate of nearly two-thirds of its deals.
BioStar Capital invests in innovative medical technologies that address unmet patient needs, with a particular emphasis on cardiovascular and orthopedic sectors. Their investment strategy includes 'smart' devices, robotics, minimally invasive solutions, cost-reduction technology, and outpatient-center technology.
BioStar Capital adds value to its portfolio companies through a unique physician-integrated General Partner model, providing clinical validation and strategic advisement from leading medical professionals. This approach enhances the development and market entry of innovative medical technologies.
BioStar Capital focuses on innovative medical technologies that address unmet patient needs, particularly in the cardiovascular and orthopedic sectors. The firm invests in early- and late-stage companies, with a preference for 'smart' devices, robotics, and minimally invasive solutions.
Startups can reach out to BioStar Capital via email at info@biostarcapital.com. It is recommended to provide a detailed pitch deck outlining the business model, market opportunity, and technology.
BioStar Capital integrates key opinion leader physicians into its General Partner model, providing unique clinical validation and strategic advisement to portfolio companies. This physician-integrated approach enhances the development and market entry of innovative medical technologies.
BioStar Capital primarily invests in companies based in the United States, focusing on the healthcare, biotech, and robotics sectors.
BioStar Capital typically invests between $1 million and $10 million in its portfolio companies, depending on the stage and potential of the business.
BioStar Capital provides ongoing support to its portfolio companies through strategic advisement from its team of healthcare clinicians and financial professionals. This includes assistance with clinical validation, market entry strategies, and operational support.
Superscout Pro
Is this page right?Reviewed · How the research works